Last reviewed · How we verify

mipomersen sodium; warfarin sodium

Kastle Therapeutics, LLC · Phase 1 active Small molecule

mipomersen sodium; warfarin sodium is a Small molecule drug developed by Kastle Therapeutics, LLC. It is currently in Phase 1 development. Also known as: Coumadin®.

At a glance

Generic namemipomersen sodium; warfarin sodium
Also known asCoumadin®
SponsorKastle Therapeutics, LLC
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about mipomersen sodium; warfarin sodium

What is mipomersen sodium; warfarin sodium?

mipomersen sodium; warfarin sodium is a Small molecule drug developed by Kastle Therapeutics, LLC.

Who makes mipomersen sodium; warfarin sodium?

mipomersen sodium; warfarin sodium is developed by Kastle Therapeutics, LLC (see full Kastle Therapeutics, LLC pipeline at /company/kastle-therapeutics-llc).

Is mipomersen sodium; warfarin sodium also known as anything else?

mipomersen sodium; warfarin sodium is also known as Coumadin®.

What development phase is mipomersen sodium; warfarin sodium in?

mipomersen sodium; warfarin sodium is in Phase 1.

Related